StocksR › ROK

Rockwell Automation, Inc. (ROK) — Earnings Call X-Ray

Our AI read all 38 of ROK's earnings calls (2016–2025) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.

Latest Call Grade
🔒
Q2 2025 · sign up to see
Previous Call Grade
C+
Q1 2025
Expected Move
🔒
next 45 days · members
Calls Analyzed
38
2016–2025
Avg Candor
7.4/9
evasion 2.1/9
High CandorSkeptic ReassuredCritic AmmunitionRaising PricesMargins ExpandingDemand AcceleratingBacklog GrowingResults Worse Than Direction

Call-by-call analysis

🔒 Q2 2025 earnings call 2025-05-07 NEWEST

Guidance: ■■■■■Demand: ■■■■■■ Margins: ■■■■Backlog: ■■■■ ■ analysts, ■■ questionsexpected move ±■■%
Candor /9
Specificity /9
Evasion /9
Stress /9

Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.

🔒 The Q2 2025 call grade is ready
The full 37-point AI read of ROK's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock

C+ Q1 2025 earnings call 2025-02-10 move ±9.5%

Management held guidance steady against accelerating demand and expanding margins. The delivery was unusually candid, rich in specifics.

Guidance: maintainedDemand: acceleratingMargins: expandingBacklog: growingPricing: raising 9 analysts · 18 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubtsDirection beats results
Candor 7/9
Specificity 8/9
Evasion 3/9
Confidence 7/9
Uncertainty 5/9
Promotion 4/9
Stress 2/9
Complexity 6/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

D Q4 2024 earnings call 2024-11-07 move ±10%

Management held guidance steady against slowing demand and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: maintainedDemand: slowingMargins: contractingBacklog: stablePricing: raisingHeadcount: cuttingCapex: increasing 8 analysts · 15 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritable✓ Early product, fast growth⚑ Reads rehearsedDirection beats results
Candor 7/9
Specificity 7/9
Evasion 3/9
Confidence 6/9
Uncertainty 6/9
Promotion 5/9
Stress 4/9
Complexity 5/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

D Q3 2024 earnings call 2024-08-07 move ±12.3%

Management lowered guidance against slowing demand and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: loweredDemand: slowingMargins: contractingBacklog: stablePricing: raisingHeadcount: cutting 10 analysts · 20 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritableDirection beats results
Candor 7/9
Specificity 8/9
Evasion 3/9
Confidence 5/9
Uncertainty 6/9
Promotion 4/9
Stress 3/9
Complexity 5/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

D Q2 2024 earnings call 2024-05-07 move ±7.2%

Management lowered guidance against slowing demand and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: loweredDemand: slowingMargins: contractingBacklog: shrinkingPricing: raisingHeadcount: cuttingCapex: decreasing 8 analysts · 16 questions
⚑ Critic ammunition⚑ Question left hanging✓ Volume step-up ahead✓ Early product, fast growthHidden segmentDirection beats results
Candor 8/9
Specificity 8/9
Evasion 2/9
Confidence 6/9
Uncertainty 5/9
Promotion 3/9
Stress 4/9
Complexity 5/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

C+ Q1 2024 earnings call 2024-01-31 move ±13.9%

Management held guidance steady against accelerating demand and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: maintainedDemand: acceleratingMargins: contractingBacklog: shrinkingPricing: raisingHeadcount: flatCapex: increasing 9 analysts · 16 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Volume step-up ahead✓ Early product, fast growth
Candor 7/9
Specificity 8/9
Evasion 2/9
Confidence 7/9
Uncertainty 3/9
Promotion 4/9
Stress 3/9
Complexity 5/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

C+ Q4 2023 earnings call 2023-11-02 move ±9.1%

Management held guidance steady against slowing demand and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: maintainedDemand: slowingMargins: contractingBacklog: shrinkingPricing: raisingHeadcount: cuttingCapex: increasing 7 analysts · 13 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Early product, fast growth⚑ Reads rehearsed
Candor 7/9
Specificity 8/9
Evasion 2/9
Confidence 7/9
Uncertainty 4/9
Promotion 5/9
Stress 3/9
Complexity 6/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

B+ Q3 2023 earnings call 2023-08-01 move ±9.4%

Management raised guidance against mixed demand signals and expanding margins. The delivery was unusually candid, rich in specifics.

Guidance: raisedDemand: mixedMargins: expandingBacklog: shrinkingPricing: raising 8 analysts · 16 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts⚑ Reads rehearsedDirection beats results
Candor 7/9
Specificity 8/9
Evasion 2/9
Confidence 8/9
Uncertainty 3/9
Promotion 4/9
Stress 2/9
Complexity 5/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

Earlier calls

CallDateGradeGuidanceDemandMarginsCandorEvasion
Q2 2023 2023-04-27 B+ raisedstableexpanding 7/9 2/9
Q1 2023 2023-01-26 A raisedacceleratingexpanding 7/9 2/9
Q4 2022 2022-11-02 C+ nonestableexpanding 7/9 3/9
Q3 2022 2022-07-27 C+ loweredstableexpanding 8/9 1/9
Q2 2022 2022-05-03 D loweredacceleratingcontracting 7/9 2/9
Q1 2022 2022-01-27 B+ maintainedacceleratingcontracting 7/9 2/9
Nov 2021 2021-11-02 A raisedacceleratingexpanding 7/9 2/9
Q3 2021 2021-07-27 A raisedacceleratingexpanding 7/9 3/9
Q2 2021 2021-04-28 A raisedacceleratingstable 8/9 2/9
Q1 2021 2021-01-26 A raisedacceleratingstable 7/9 2/9
Q4 2020 2020-11-10 A maintainedacceleratingstable 7/9 1/9
Q3 2020 2020-07-28 B+ raisedmixedcontracting 8/9 2/9
Q2 2020 2020-04-28 C loweredslowingcontracting 7/9 2/9
Q1 2020 2020-01-29 B+ maintainedmixedcontracting 8/9 1/9
Q4 2019 2019-11-12 B+ loweredslowingstable 7/9 2/9
Q3 2019 2019-07-25 D loweredslowingexpanding 7/9 4/9
Q2 2019 2019-04-25 C+ loweredmixedexpanding 8/9 2/9
Q1 2019 2019-01-29 B maintainedmixedexpanding 7/9 2/9
Q4 2018 2018-11-07 B maintainedstableexpanding 8/9 2/9
Q3 2018 2018-07-25 A raisedacceleratingexpanding 7/9 3/9
Q2 2018 2018-04-25 A raisedacceleratingexpanding 7/9 2/9
Q1 2018 2018-01-24 B+ raisedstableexpanding 8/9 1/9
Q4 2017 2017-11-08 C maintainedacceleratingcontracting 8/9 5/9
Q3 2017 2017-07-26 A raisedacceleratingstable 8/9 1/9
Q2 2017 2017-04-26 A raisedacceleratingcontracting 7/9 2/9
Q1 2017 2017-01-25 B+ raisedacceleratingexpanding 8/9 2/9
Q4 2016 2016-11-07 B+ maintainedmixedcontracting 8/9 1/9
Q3 2016 2016-07-27 C loweredmixedstable 8/9 2/9
Q2 2016 2016-04-27 B+ maintainedmixedcontracting 8/9 2/9
Q1 2016 2016-01-27 C loweredslowingcontracting 8/9 1/9

Research question bank — earlier calls

During our 1,600-question research program, batches of experimental hypotheses were tested directly against some of ROK's earlier calls. The YES answers — the rare hits — are shown; click any question to see every company that matched it. Full list: the question bank.

B+ Q1 2022 earnings call 2022-01-27

1 more research questions answered NO

A Nov 2021 earnings call 2021-11-02

1 more research questions answered NO

C Q4 2017 earnings call 2017-11-08

320 more research questions answered NO

How to read this page

The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.

Companies with similar call quality

AA · Alcoa CorporationAAALF · Aareal Bank AGAABKF · Aareal Bank AGAAGIY · AIA Group LimitedAAL · American Airlines Group AAPL · Apple Inc.

ROIV   All “R” companies    ROKA

Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.